Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon Injection for Postoperative Pain in Laparoscopic Hepatectomy
NCT07826806Phase 2Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Phase 2 trial of hsk21542 in postoperative pain, sponsored by Tianjin Medical University Cancer Institute and Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07826806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826806.